Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver

To investigate the potential of therapies which reduce glucocorticoid action in patients with Type 2 diabetes we performed a randomized, double-blinded, placebo-controlled crossover study of acute glucocorticoid blockade, using the glucocorticoid receptor antagonist RU38486 (mifepristone) and cortis...

Descripción completa

Detalles Bibliográficos
Autores principales: Macfarlane, D. P., Raubenheimer, P. J., Preston, T., Gray, C. D., Bastin, M. E., Marshall, I., Iredale, J. P., Andrew, R., Walker, B. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Physiological Society 2014
Materias:
Hormones and Signaling
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187063/
https://www.ncbi.nlm.nih.gov/pubmed/25104497
http://dx.doi.org/10.1152/ajpgi.00030.2014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187063/
https://www.ncbi.nlm.nih.gov/pubmed/25104497
http://dx.doi.org/10.1152/ajpgi.00030.2014

Ejemplares similares